ISRSy

📣 DON’T FORGET: The next#ISRSWebinar

Title: Non-Surgical Treatments for Early-Stage Lung Cancer

📅 When: 10 November 2026, 17:00–18:00 CET
🎙️ Speaker: Dr. Drew Moghanaki

This webinar will review the latest data on non-surgical treatments for patients with resectable and unresectable early-stage lung cancer. It will cover treatment utilization trends, single-fraction lung SBRT, and strategies to optimize outcomes for locally advanced lung cancer, with updates on ongoing Phase III trials.

🎥 This webinar features a pre-recorded presentation prepared by the speaker.
Register here: us06web.zoom.us/webinar/regist…

📢 We are pleased to announce our upcoming ISRS webinar!

Title: Non-Surgical Treatments for Early-Stage Lung Cancer

📅 When: 10 November 2026, 17:00–18:00 CET
🎙️ Speaker: Dr. Drew Moghanaki

This webinar will review the latest data on non-surgical treatments for patients with resectable and unresectable early-stage lung cancer. It will cover treatment utilization trends, single-fraction lung SBRT, and strategies to optimize outcomes for locally advanced lung cancer, with updates on ongoing Phase III trials.

🎥 This webinar features a pre-recorded presentation prepared by the speaker.

Register here: us06web.zoom.us/webinar/regist…

📣 HAPPENING TOMORROW: The Next #ISRSWebinar
In partnership with Varian (A Siemens Healthineers Company), an ISRS corporate sponsor.

🧠 SRS for Multiple Brain Metastases: Clinical Experience and the Future of AI-based Automated Segmentation

🥼 Raju Raval, MD, DPhil
🗓️ October 22, 2026 | 4:00 PM CEST

Join us for an insightful webinar exploring the role of stereotactic radiosurgery (SRS) in the treatment of multiple brain metastases, including its clinical feasibility for patients with more than 15 metastases.

The session will also introduce AI-based segmentation of brain metastases and examine how automated contouring may improve efficiency, consistency, and clinical workflows.

Learn from real-world clinical experience and discover how artificial intelligence may help shape the future of radiosurgery practice.

Register here:
us06web.zoom.us/webinar/regist…

📣 DON’T FORGET: The next hashtag#ISRSWebinar
In partnership with Varian (A Siemens Healthineers Company), an ISRS corporate sponsor.

🧠 SRS for Multiple Brain Metastases: Clinical Experience and the Future of AI-based Automated Segmentation

🥼 Dr. Raju Raval, MD, DPhil
🗓️ October 22, 2026 | 4:00 PM CEST

Join us for an insightful webinar exploring the role of stereotactic radiosurgery (SRS) in the treatment of multiple brain metastases, including its clinical feasibility for patients with more than 15 metastases.

The session will also introduce AI-based segmentation of brain metastases and examine how automated contouring may improve efficiency, consistency, and clinical workflows.

Learn from real-world clinical experience and discover how artificial intelligence may help shape the future of radiosurgery practice.

🔗 Register here:
us06web.zoom.us/webinar/regist…

#ISRSWebinar#ISRS#Radiosurgery#ISRS #BrainMetastases#ArtificialIntelligence #AI #Radiotherapy #RadiationOncology #MedicalEducation

📣 ANNOUNCING: The next hashtag#ISRSWebinar

"SRS for Multiple Brain Metastases: Clinical Experience and the Future of AI-based Automated Segmentation"

🥼 Dr. Raju Raval
🗓️ October 22, 2026 | 4:00 PM CEST
In partnership with Varian (A Siemens Healthineers Company)

Join us for an insightful webinar exploring the role of stereotactic radiosurgery (SRS) in the treatment of multiple brain metastases, including its clinical feasibility for patients with more than 15 metastases.

This session will also introduce AI-based segmentation of brain metastases and examine how automated contouring may improve efficiency, consistency, and clinical workflows for this patient population.

Learn about real-world clinical experience, emerging technologies, and the future potential of artificial intelligence in radiosurgery practice.

Register here:
us06web.zoom.us/webinar/regist…